These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1815971)

  • 21. A clinical pharmacological study of subcutaneous nicotine.
    Le Houezec J; Jacob P; Benowitz NL
    Eur J Clin Pharmacol; 1993; 44(3):225-30. PubMed ID: 8491235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic study.
    Illum L; Davis SS; Pawula M; Fisher AN; Barrett DA; Farraj NF; Shaw PN
    Biopharm Drug Dispos; 1996 Nov; 17(8):717-24. PubMed ID: 8950049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of nasal, intravenous, and oral methadone in healthy volunteers.
    Dale O; Hoffer C; Sheffels P; Kharasch ED
    Clin Pharmacol Ther; 2002 Nov; 72(5):536-45. PubMed ID: 12426517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasal absorption of dihydroergotamine from liquid and powder formulations in rabbits.
    Marttin E; Romeijn SG; Verhoef JC; Merkus FW
    J Pharm Sci; 1997 Jul; 86(7):802-7. PubMed ID: 9232520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment.
    Vachharajani NN; Shyu WC; Garnett WR; Morgenthien EA; Barbhaiya RH
    Clin Pharmacol Ther; 1996 Sep; 60(3):283-94. PubMed ID: 8841151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous nicotine retards transdermal absorption of nicotine: evidence of blood flow--limited percutaneous absorption.
    Benowitz NL; Jacob P; Olsson P; Johansson CJ
    Clin Pharmacol Ther; 1992 Sep; 52(3):223-30. PubMed ID: 1526077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of nicotine in kidney failure.
    Molander L; Hansson A; Lunell E; Alainentalo L; Hoffmann M; Larsson R
    Clin Pharmacol Ther; 2000 Sep; 68(3):250-60. PubMed ID: 11014406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans.
    Gudmundsdottir H; Sigurjonsdottir JF; Masson M; Fjalldal O; Stefansson E; Loftsson T
    Pharmazie; 2001 Dec; 56(12):963-6. PubMed ID: 11802661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance.
    Hukkanen J; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2006 Nov; 80(5):522-30. PubMed ID: 17112808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal nicotine spray: a rapid nicotine delivery system.
    Sutherland G; Russell MA; Stapleton J; Feyerabend C; Ferno O
    Psychopharmacology (Berl); 1992; 108(4):512-8. PubMed ID: 1410168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on the nasal absorption of gentamycin].
    Wang J; Bu G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(3):134-6. PubMed ID: 7803102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.
    Shyu WC; Pittman KA; Robinson DS; Barbhaiya RH
    Eur J Clin Pharmacol; 1993; 45(6):559-62. PubMed ID: 8157043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human pharmacokinetics of dihydroergotamine administered by nasal spray.
    Humbert H; Cabiac MD; Dubray C; Lavène D
    Clin Pharmacol Ther; 1996 Sep; 60(3):265-75. PubMed ID: 8841149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of tobacco smoking and nasal nicotine.
    Teter CJ; Asfaw B; Ni L; Lutz M; Domino EF; Guthrie SK
    Eur J Clin Pharmacol; 2002 Aug; 58(5):309-14. PubMed ID: 12185553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and bioavailability of nicotine in healthy volunteers following single and repeated administration of different doses of transdermal nicotine systems.
    Dubois JP; Sioufi A; Müller P; Mauli D; Imhof PR
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):187-95. PubMed ID: 2725117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal absorption of physostigmine and arecoline.
    Hussain MA; Mollica JA
    J Pharm Sci; 1991 Aug; 80(8):750-1. PubMed ID: 1791534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of nicotine tartrate after single-dose liquid enema, oral, and intravenous administration.
    Zins BJ; Sandborn WJ; Mays DC; Lawson GM; McKinney JA; Tremaine WJ; Mahoney DW; Zinsmeister AR; Hurt RD; Offord KP; Lipsky JJ
    J Clin Pharmacol; 1997 May; 37(5):426-36. PubMed ID: 9156375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
    Bergman A; Ebel D; Liu F; Stone J; Wang A; Zeng W; Chen L; Dilzer S; Lasseter K; Herman G; Wagner J; Krishna R
    Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of tiapride and absolute bioavailability of three extravascular forms.
    Rey E; d'Athis P; Richard MO; de Lauture D; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):62-7. PubMed ID: 7061180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An experimental study on nasal absorption of gentamycin in dogs.
    Wang JQ; Bu GX
    Chin Med J (Engl); 1994 Mar; 107(3):219-21. PubMed ID: 8088184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.